Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2020-10-30 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Exercise of Options and Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC regarding the allotment of new ordinary shares following the exercise of share options. It explicitly mentions the total number of voting rights post-admission. This falls under the category of share issuance and capital changes.
2020-10-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to notify the issuer and the FCA when their voting rights cross certain thresholds. This specific document details Legal & General Group Plc's change in shareholding in Omega Diagnostics Group Plc. This falls directly under the 'Major Shareholding Notification' category.
2020-10-29 English
Trading update and notice of interim results
Earnings Release Classification · 1% confidence The document is a 'Trading update and notice of interim results' issued by Omega Diagnostics Group PLC. It provides preliminary financial figures (turnover, EBITDA, segmental revenues) and operational updates in advance of the full interim report release. According to the 'Menu vs Meal' rule, this is an announcement of upcoming results and a summary of current trading performance, which fits the definition of an Earnings Release (ER) as it provides key financial highlights before the full report is published. H1 2020
2020-10-28 English
Exercise of Options and Total Voting Rights
Director's Dealing Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC regarding the exercise of share options by a PDMR (Person Discharging Managerial Responsibilities) and the subsequent sale of those shares. It also includes a formal notification of the transaction as required by the EU Market Abuse Regulation. While it mentions total voting rights, the primary purpose is to report a director's/manager's dealing and the resulting change in share capital. According to the provided definitions, 'Director's Dealing' (DIRS) is the most specific category for reporting personal share transactions by company executives, and the document explicitly includes the required PDMR disclosure table.
2020-10-20 English
Notice of Trading Update and Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Omega Diagnostics Group PLC regarding the upcoming release of a trading update and an invitation to an investor presentation. It does not contain the actual financial report or the presentation slides themselves, but rather serves as a notification of their scheduled publication and event timing. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2020-10-20 English
UK-RTC contract for the Supply of Goods
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Omega Diagnostics Group PLC regarding a commercial contract for the supply of goods (COVID-19 tests) to the UK-RTC. It is a corporate announcement of a business development/contract win rather than a financial report, proxy statement, or governance document. Since it does not fit into specific categories like M&A (TAR) or Capital/Financing (CAP) and is a general regulatory disclosure of inside information, it falls under the RNS category.
2020-10-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.